2010 Federal Circuit Highlights

Refresh your understanding of Federal Circuit case law in this program designed especially for IP lawyers practicing in biotechnology. Federal Circuit decisions can impact IP portfolio strategy on many levels and in significant or subtle ways. We have selected some decisions of particular importance that are worth a closer look.

Please join Finnegan attorneys Leslie A. McDonell and Amelia Feulner Baur, Ph.D., as they discuss the following biotechnology cases: 

- Prometheus Laboratories Inc. v. Mayo Collaborative Services, et al. 

    - Method of treatment claims and 35 U.S.C. § 101

- Cancer Research Technology Ltd. v. Barr Laboratories, Inc. 

    - Prosecution latches and inequitable conduct

- Sun Pharmaceuticals Industries, Inc. v. Eli Lilly and Company 

    - Double patenting

Date:

Thursday, February 17, 2011

Time:

7:30 - 8:00 a.m.

Registration and Breakfast

8:00 - 9:00 a.m.

Program

Where:

Finnegan

55 Cambridge Parkway

Cambridge, MA